Alternatively, Foxp3+ Tregs can also be generated in vitro by IL-2, and TGF-β from naïve CD4+T cells [17], but little is known about the potential of peripheral Tregs from CKD patients as a source for an in vitro generated therapeutic cell product. The gene discussed is FOXP3; the disease is chronic kidney disease.